PhRMA Reconsiders Medicare Stance For 2000: Incremental Reform Weighed
Executive Summary
The linchpin legislative policy decision facing PhRMA for 2000 is whether to endorse an incremental drug benefit that stops short of comprehensive Medicare reform.